Printer Friendly

BrainStorm names Eyal Rubin as CFO.

M2 PHARMA-November 3, 2017-BrainStorm names Eyal Rubin as CFO

(C)2017 M2 COMMUNICATIONS

Adult stem cell company BrainStorm Cell Therapeutics Inc (NASDAQ:BCLI) announced on Thursday the election of Eyal Rubin as its chief financial officer.

In the new senior position, Rubin will be responsible for all corporate finance and accounting activities for the company

Most recently, Rubin has served as vice president and head of Corporate Treasury at Teva Pharmaceutical Industries Ltd, positions he has held since 2013.

Previously, Rubin was employed as finance & banking manager for Cellcom Israel LTD, chief financial officer for IDT Carmel as well as general manager and chief financial officer for V-Secure Technologies.

Earlier in his career, Rubin has worked as the chief operating officer and vice president Finance for Sec2Wireless from 1999-2003,

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Nov 3, 2017
Words:140
Previous Article:RayStation selected as treatment planning system for CYCLHAD Hadrontherapy Centre, France.
Next Article:Gallagher Named Editor in Chief of Contagion.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |